About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medicines Information
Adverse Drug Reactions
Clinical guidelines
Compliance
Drug Alerts
Drug Interactions
Drug reviews
Drug shortages
Drugs in lactation
Drugs in liver disease
Drugs in paediatrics
Drugs in pregnancy
Drugs in renal failure
FAQs
General Advice
Horizon scanning
Medication errors
Pharmaceutical Industry
Pharmaceutics
Product Discontinuation
Product Licence Changes
Toxicology & poisoning
Travel health
Unlicenced medicines
3004 library items
in Adverse Drug Reactions
Filter results by:
Date Published
2012 (67)
2011 (709)
2010 (687)
2009 (420)
2008 (425)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Adverse Drug Reactions (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 3004
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
FDA Safety Communication: Proton pump inhibitors and Clostridium Difficile-associated diarrhoea
Source:
FDA
,
Date published:
09/02/2012
Category:
1.3.1 H2-receptor antagonists
|
1.3.5 Proton pump inhibitors
|
Adverse Drug Reactions
|
Bacterial
|
Food &Drug Administration (FDA)
|
Infection
NeLM
Area:
News
Link
2.
Do gastric adverse events influence the choice of bisphosphonate for the treatment of osteoporosis?
Source:
Regional Drug and Therapeutics Centre
,
Date published:
08/02/2012
Review date:
31/01/2014
Category:
6.6 Drugs affecting bone metabolism
|
Adverse Drug Reactions
NeLM
Area:
Evidence
>
Medicines Q & A
Do gastric adverse events influence the choice of bisphosphonate for the treatment of osteoporosis?
3.
Nocebo effects, patient-clinician communication, and therapeutic outcomes
Source:
Journal of the American Medical Association
,
Date published:
08/02/2012
Category:
Adverse Drug Reactions
NeLM
Area:
Evidence
>
Medicines Management
>
References
Extract link
4.
Suicidal thoughts and behaviour with antidepressant treatment: Reanalysis of fluoxetine and venlafaxine RCTs
Source:
Arch Gen Psychiatry
,
Date published:
07/02/2012
Category:
4.3 Antidepressant drugs
|
Adverse Drug Reactions
|
Mood disorders (including depression)
|
Suicide
NeLM
Area:
News
Link (abstract)
5.
Subanalysis of the MAP.3 study finds exemestane for primary prevention of breast cancer worsens age-related BMD decreases
Source:
Lancet Oncology
,
Date published:
07/02/2012
Category:
8.3.4 Hormone antagonists
|
Adverse Drug Reactions
|
Cancer: breast
NeLM
Area:
News
Link (abstract)
Comment
MAP.3 study results (NeLM report)
6.
The US Food and Drug Administration's Mini-Sentinel program: status and direction
Source:
Pharmacoepidemiology and Drug Safety
,
Date published:
07/02/2012
Category:
Adverse Drug Reactions
|
Food &Drug Administration (FDA)
|
IT
NeLM
Area:
Evidence
>
Medicines Management
>
References
Full text link (PDF)
7.
Assuring the safety and effectiveness of new drugs: rigorous phase IV trials randomizing general practices to delayed access to new drugs
Source:
Journal of Health Services Research and Policy
,
Date published:
07/02/2012
Category:
Adverse Drug Reactions
|
General practice
NeLM
Area:
Evidence
>
Medicines Management
>
References
Abstract link
8.
Opportunity lost? Psychiatric medications and problems with sexual function: a role for nurses in mental health
Source:
Journal of Clinical Nursing
,
Date published:
07/02/2012
Category:
4: Central nervous system
|
Adverse Drug Reactions
|
Compliance
NeLM
Area:
Evidence
>
Medicines Management
>
References
Abstract link
9.
Addition of thalidomide to paclitaxel and carboplatin shows no benefit in patients with NSCLC
Source:
Journal of Clinical Oncology
,
Date published:
06/02/2012
Category:
8.2.4 Other immunomodulating drugs
|
Adverse Drug Reactions
|
Cancer: lung
NeLM
Area:
News
Abstract
10.
Cholestasis secondary to anabolic steroid use in young men
Source:
BMJ
,
Date published:
03/02/2012
Category:
6.4.3 Anabolic steroids
|
Adverse Drug Reactions
|
Liver disease
NeLM
Area:
News
Article
Results 1 - 10 of 3004
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next